Randomized, double-blinded, placebo controlled study of the effects of modafinil on cognitive function in patients with schizophrenia and normal controls based on COMT genotype
Phase of Trial: Phase I
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Modafinil (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics; Pharmacogenomic
- 17 Jun 2017 Status changed from active, no longer recruiting to completed.
- 05 May 2017 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 05 May 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.